医学
血运重建
内科学
心脏病学
心肌梗塞
队列
急诊科
急性冠脉综合征
诊断试验中的似然比
置信区间
接收机工作特性
精神科
作者
Antonius Büscher,Lucas Plagwitz,Kemal Yildirim,Tobias Brix,Philipp Neuhaus,Lucas Bickmann,Amélie Friederike Menke,Vincent F van Almsick,Hermann Pavenstädt,Philipp Kümpers,Dominik Heider,Julian Varghese,Lars Eckardt
标识
DOI:10.1093/eurheartj/ehaf254
摘要
Abstract Background and Aims Identification of patients with acute coronary syndrome requiring coronary revascularization can be challenging due to inconclusive electrocardiogram (ECG) findings or biomarker results. A deep learning model to detect ECG patterns associated with revascularization likelihood was developed, aiming to guide further assessment and reduce diagnostic uncertainty. Methods A convolutional neural network model was trained on 144 691 ED visits from a US cohort (60 ± 19 years; 53% female; 0.6% revascularization), tested on a separate test cohort (n = 35 995), and benchmarked against clinician ECG interpretation and cardiac troponin T (TnT). External validation was performed for the outcomes revascularization and Type 1 myocardial infarction (MI) on 18 673 ED visits from Europe (55 ± 21 years; 49% female; 1.5% revascularization; 1% Type 1 MI). Primary performance metric was area under the receiver operating characteristic curve (AUROC). Results In the test cohort, the model achieved an AUROC of 0.91 (95% confidence interval [CI] 0.91–0.91), outperforming clinician ECG interpretation (AUROC 0.65, 95% CI 0.54–0.76) and conventional cardiac TnT (AUROC 0.71). In the external validation cohort, ECG model AUROC was 0.81 (95% CI 0.81–0.82) for revascularization, and 0.85 (95% CI 0.84–0.85) for Type 1 MI, compared with 0.70 (95% CI 0.57–0.83) and 0.74 (95% CI 0.56–0.92) for clinician interpretation, and 0.85 and 0.87 for high-sensitivity (hs)-TnT, respectively. The ECG model had higher specificity but lower sensitivity compared with high-sensitivity-troponin T. Conclusions The model was able to detect revascularization and Type 1 MI with competitive performance, suggesting a potential role to complement current clinical assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI